GARDP & Bugworks to Accelerate Development of a Novel Antibiotic to Treat Serious Bacterial Infections
Kevin Outterson is quoted.
July 28, 2023 PharmaBizRunning Out of Options, Lawmakers Search for Solutions to Antibiotic Resistance
July 11, 2023 Kevin Outterson is interviewed.Running Out of Options, Lawmakers Search for Solutions to Antibiotic Resistance
Kevin Outterson is quoted.
July 11, 2023 National JournalBIO International Convention
Kevin Outterson will speak at the BIO International Convention from June 5th through 8th. Hosted in Boston, the BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Innovative programming around the current and future state of biotech, including areas like therapeutic frontiers, […]
House Subcommittee Focuses on Antimicrobial Resistance
Kevin Outterson is mentioned.
June 2, 2023 Policy & MedicineHealth Care Week in Review: House Passes Debt Limit Bill, CMS Proposes Rules
Kevin Outterson is mentioned.
May 3, 2023 JD SupraHearing on Public Health Threat from AMR Puts Spotlight on PASTEUR Act
Kevin Outterson is mentioned.
May 3, 2023 Bio.NewsOversight and Investigations Subcommittee Hearing: “Antimicrobial Resistance: Examining an Emerging Public Health Threat”
Kevin Outterson testifies at House Energy & Commerce Subcommittee on Oversight and Investigations Hearing.
April 28, 2023 Energy & Commerce CommitteeCan Congress Fix the Problem of Antimicrobial Resistance?
Kevin Outterson is quoted.
April 12, 2023 National JournalRecognizing Excellence in Faculty
When Boston University School of Law Professor Kevin Outterson was named the Austin B. Fletcher Professor of Law last fall in recognition of his research, teaching, and scholarship, he assumed a title that dates back nearly a century.